AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Advanced Biomed Inc. Common Stock
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG01HW4B3N3
3.17▼ 0.29 (-8.38%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
3.46
Day's Range
3.15 – 3.62
52-Week Range
0.19 – 24.23
Volume
21.8K
Avg Volume
32.0K
Share Statistics
Shares Outstanding
Employees
31
Exchange
XNAS
Listed
2025-03-06
Share count as of October 13, 2026

Advanced Biomed Inc. Common Stock (ADVB) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Advanced Biomed Inc. Common Stock (ADVB)
What is Advanced Biomed Inc. Common Stock's Market Cap?
Advanced Biomed Inc. Common Stock's Market Cap is $5.2M, based on as-reported figures from SEC (XBRL) filings.
What is Advanced Biomed Inc. Common Stock's Trailing P/E?
Advanced Biomed Inc. Common Stock's Trailing P/E is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is Advanced Biomed Inc. Common Stock's Net Income (TTM)?
Advanced Biomed Inc. Common Stock's Net Income (TTM) is $5.3M, based on as-reported figures from SEC (XBRL) filings.
What is Advanced Biomed Inc. Common Stock's Diluted EPS (TTM)?
Advanced Biomed Inc. Common Stock's Diluted EPS (TTM) is 3.20, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ADVBAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023
Operating expenses:
General and administrative expenses
Total operating expenses
Other expense:
Interest expense——
Other expenses, net
Total other expenses, net
Loss before income tax expense
Loss from continuing operations—
Net income from discontinued operations, net of tax—
Net income (loss) for the year
Total income (loss) per share, basic (in Dollars per share)
Total income (loss) per share, diluted (in Dollars per share)